2XSW
Crystal structure of human INPP5E
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID29 |
Synchrotron site | ESRF |
Beamline | ID29 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2010-09-13 |
Detector | DECTRIS PILATUS 6M |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 50.528, 103.579, 137.545 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 48.468 - 1.900 |
R-factor | 0.1665 |
Rwork | 0.165 |
R-free | 0.19470 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1i9y |
RMSD bond length | 0.011 |
RMSD bond angle | 1.287 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | BALBES |
Refinement software | PHENIX ((PHENIX.REFINE)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 48.470 | 2.000 |
High resolution limit [Å] | 1.900 | 1.900 |
Rmerge | 0.070 | 0.460 |
Number of reflections | 56918 | |
<I/σ(I)> | 7.6 | 0.9 |
Completeness [%] | 98.5 | 97.3 |
Redundancy | 6.7 | 6.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 7 | PROTEIN WAS INCUBATE WITH 1MM PHOSPHATIDYLINOSITOL-3,4,5-TRIPHOSPHATE AND 2MM MGCL2 PRIOR SETTING-UP THE PLATES. PROTEIN WAS THEN CRYSTALLIZED AGAINST 0.2M MGCL2, 10% W/V PEG8K AND 0.1M TRIS PH 7. |